Investors

To download our documents

Live stock price

OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris

Share price

ISIN

FR0012127173

Ticker

OSE

Type of listing

Continuous

Number of outstanding shares

22,910,181 shares as of June 30, 2025

Eligibility

Eligible to Long-Only Deferred Settlement Service

Financial calendar

This calendar is indicative and may be amended. Financial results are published after market close (Euronext Growth Paris).

26 March 2025

Annual financial results 2024

25 September 2025

Half-year results 2025

30 September 2025

General shareholders' meeting (subject to the evolution of ongoing legal proceedings)

Analysts

Read more
Edison
Arron Aatkar
Invest Securities
Jamila El Bougrini
Kepler Cheuvreux
Pierre-Alexandre Desir

Analyst reports

Read more
18/06/2025 All invest Securities: AG SUR FOND DE TENSIONS : DIVERGENCE STRATÉGIQUE À L’ODJ
05/06/2025 Edison: New UC biomarker underpins growth strategy
03/06/2025 Edison: ASCO 2025 update showcases Tedopi potential

Regulated information

Read more
30/06/2025 Letter to Shareholders

Professional Equality Index

Read more
25/02/2025 Index égalité professionnelle 2025
27/02/2024 Index égalité professionnelle 2024

General shareholders' meetings

Read more
04/06/2025

General Shareholders' Meeting 2025

All the documents below are in French except the 'Board observations on new resolutions requests' and the Voting form

Financial information and publications

Read more
2024 First-half 2024 semester report (in French)
2024 2023 Universal registration document
2023 Auditors's report on first-half 2023 financial report (in French)

To receive OSE Immunotherapeutics’ latest news